Small RNA Sequencing via Ribosomal Masking and Template Switching

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for sequencing short RNAs are hindered by the need for large amounts of starting material, contamination from ribosomal RNA, and biases in sample preparation, making it difficult to achieve sensitive and reliable quantification, especially for single cells or complex tissues.

Innovation Solution

A method involving masking ribosomal RNA, ligating adaptors to small RNA molecules, and performing reverse transcription and PCR to enable sequencing and quantification without size selection, suitable for single cell analysis and automation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If gel-based assays, microarrays, or real-time PCR are used for sRNA profiling, then detection of known RNA sequences is possible, but target amplification is difficult due to the short size of sRNAs and high input target concentration is required

Engineering Contradiction:
Improvedetection sensitivityVSAvoidinput target concentration
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The patent performs size selection of sRNAs before the main sequencing workflow, and uses template switching oligos with specific sequences designed to facilitate efficient reverse transcription and PCR amplification of short RNA molecules. These preliminary preparations address the amplification difficulty inherent to short sRNAs.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent introduces template switching oligos as intermediaries that bridge the gap between short sRNA molecules and the sequencing library preparation workflow. These oligos contain sequences that facilitate efficient binding and extension, enabling amplification of short targets that would otherwise be difficult to amplify.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If next generation sequencing-based sRNA profiling is performed, then high throughput and comprehensive sequencing is achieved, but much larger amounts of starting material are required compared to longer RNA fragments

Engineering Contradiction:
Improvesequencing throughputVSAvoidstarting material amount
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent performs size selection to enrich for sRNAs of specific lengths (18-30 nucleotides) before library preparation and sequencing. This preliminary enrichment step increases the proportion of target molecules in the sample, enabling efficient sequencing with limited starting material.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent optimizes various parameters including the size selection range, adapter ligation conditions, and PCR cycling parameters to maximize the efficiency of library preparation from minimal sRNA input while maintaining high sequencing throughput.

Inventive Principle:
Principle #35Parameter changes

3Manufacturing precision

If size selection steps are included in sRNA sequencing protocols, then sequencing accuracy is improved, but implementation complexity and time consumption increase

Engineering Contradiction:
Improvesequencing accuracyVSAvoidprotocol implementation complexity
Core Design Contradiction:
Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent performs size selection as a preliminary step using gel electrophoresis or size-exclusion chromatography to separate sRNAs by length. This preliminary purification ensures that only the desired size range proceeds to library preparation, improving sequencing accuracy while establishing a clear workflow structure.

Inventive Principle:
Principle #10Preliminary action

4Quantity of substance

If bulk RNA analysis is performed instead of single cell analysis, then sufficient RNA quantity is available for sequencing, but resolution of RNA expression on single cell level is lost

Engineering Contradiction:
ImproveRNA quantityVSAvoidsingle cell resolution
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent divides the sample into individual single cells and processes each cell separately through the sRNA sequencing workflow. This segmentation enables measurement of sRNA expression at single-cell resolution while the optimized protocol ensures sufficient RNA is captured and processed from each individual cell.

Inventive Principle:
Principle #1Segmentation

Solution Approach 2:

The patent uses whole transcriptome amplification and template switching oligos as intermediaries to amplify the limited RNA content from single cells to levels sufficient for sequencing, while preserving the single-cell identity through barcoding or separate processing.

Inventive Principle:
Principle #24Intermediary (Mediator)

5Ease of manufacture

If traditional sRNA profiling methods are used, then established protocols are available, but detection of rare targets and post-assay validation with more sensitive assays is required

Engineering Contradiction:
Improveprotocol availabilityVSAvoidrare target detection sensitivity
Core Design Contradiction:
Ease of manufactureVSMeasurement precision

Solution Approach 1:

The patent performs size selection and enrichment of sRNAs before sequencing, and uses optimized adapter ligation and PCR conditions to preferentially amplify rare targets. This preliminary enrichment improves the detection sensitivity for rare sRNA species without requiring post-assay validation.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for high-sensitivity, reproducible, and quantitative analysis of short RNA sequences from small amounts of material, reducing contamination effects and biases, and facilitating the detection of rare RNA species in complex mixtures.

Implementation Method 1

masking ribosomal RNA molecules by providing one or more oligonucleotide(s) complementary to the RNA to be masked

Methodology Applied
Scientific EffectHybridization:

Implementation Method 2

ligating a 3' oligonucleotide adaptor to the 3' end of small RNA molecules

Methodology Applied
Scientific EffectLigation:

Implementation Method 3

performing reverse transcription of the RNA

Methodology Applied
Scientific EffectReverse transcription:

Data Source

PatentUS11441169B2Methods of small-RNA transcriptome sequencing and applications thereof
Publication Date: 2022.09.13 LUDWIG INSTITUTE FOR CANCER RESEARCH LTD
  • US11441169B2 patent drawing
  • US11441169B2 patent drawing
  • US11441169B2 patent drawing

AI summary

Methods and kits for sequencing and quantification of small RNA molecules from small quantities of starting materials, including single cells, are disclosed. The invention can be applied to, among others, preparing small RNA libraries, synthesizing cDNA from small RNAs, characterizing small RNAs from various cell types, studying cellular heterogeneity in pathological conditions, and diagnosing diseases.